(30 days)
Not Found
No
The document describes a standard ultrasonic A and B scan system for ophthalmic diagnostics and biometry. There is no mention of AI, ML, or any related technologies in the intended use, device description, or performance studies. The clinical testing section explicitly states that clinical tests are not required because the device uses the same technology as existing devices, which is not typical for devices incorporating novel AI/ML algorithms.
No
The device is described as a diagnostic imaging system for the eye and for biometric measurements, which are diagnostic purposes, not therapeutic.
Yes.
The "Intended Use / Indications for Use" section explicitly states "The intended use of the Cinescan S is for diagnostic imaging of the eye by A and B scans and for biometric measurements of the eye." This directly indicates its role in diagnosis.
No
The device description explicitly states it is a "combined ophthalmic A and B scan system," which implies hardware components (transducers, system unit) are included, not just software.
Based on the provided information, the Quantel Medical Cinescan S is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs are used to examine specimens derived from the human body. The intended use and device description clearly state that the Cinescan S is used for diagnostic imaging and biometric measurements of the eye using ultrasonic means. This involves direct interaction with the patient's eye, not the analysis of a biological sample taken from the patient.
- The device description and intended use focus on imaging and measurement. The functions described are related to visualizing the eye's internal structures (A and B scans) and measuring its dimensions (axial length). These are typical functions of medical imaging and biometric devices, not IVDs.
Therefore, the Quantel Medical Cinescan S falls under the category of a medical device used for diagnostic imaging and measurement, not an IVD.
N/A
Intended Use / Indications for Use
The Quantel Medical Cinescan S is intended to be used for:
- the Axial Length measurement of the eye by ultrasonic means
- the implanted IOL power calculation, using the Axial Length measurement.
- Visualization of the interior of the eye by A and B scans.
The intended use of the Cinescan S is for diagnostic imaging of the eye by A and B scans and for biometric measurements of the eye.
The intended use of the Cinescan S 10 MHz B-scan transducer is for diagnostic imaging of the eye by B scans.
The Quantel Medical Cinescan S Mhz A-scan transducer is intended to be used with the Quantel Cinescan S A-scans of the eye and for biometric measurements.
The intended use of the Cinescan S is for diagnostic imaging of the eye by B scans and for biometric measurements of the eye.
Product codes (comma separated list FDA assigned to the subject device)
90 HPR and IYO
Device Description
The Cinescan S is a combined ophthalmic A and B scan system that can also be used for biometric measurements of the eye and for IOL calculations.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasonic
Anatomical Site
Eye
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
(a) Non-Clinical tests
- for Electrical Security IEC 601-1 .
- IEC 601-1-2 for Electromagnetic Compatibility E
- FDA transducer emissions tests 赢
(b) Clinical tests
Since the Cinescan uses the same technology as existing devices, clinical tests are not required.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1560 Ultrasonic pulsed echo imaging system.
(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
JUN 2 1 2002
Ko21683
1082
Special 510(k)
Cinescan S Ultrasonic Ophthalmic A and B scan System
510(k) Summary
Page :A 1 / 2
Special 510(k)
(1) Submitter information
Quantel Medical S.A.
Name : | Quantel Medical S.A. |
---|---|
Address: | 21 rue Newton - Zone du BREZET |
Clermont-Ferrand | |
63039 France | |
Telephone: | 33-473-745 745 |
Contact person: | Dr. George MYERS (Official Correspondent). |
Medsys Inc. | |
377 Route 17 South | |
Hasbrouck Heights, New Jersey 07064 | |
Tel : 201-727-1703 | |
Fax: 201-727-1708 | |
Date prepared : | April 10, 2002 |
(2) Name of Device
Trade Name: | "Cinescan S" Ophthalmic Ultrasound System |
---|---|
Common Name: | Ophthalmic A and B scan ultrasound system |
Classification name: | System, Imaging, Ultrasonic, Ophthalmic, 980IYO |
(3) Legally-marketed predicate device
The predicate devices are:
- The "B-SCAN", K926521, manufactured by Biovision and then B.V.I (the predecessor company to Quantel Medical). This device included both A and B scan capability. 2. The Axis II, K000554, manufactured by Quantel Medical. This was the subject of a Special 510(k), and was also a modification of the "B-scan." A number of modifications cleared with the previous 510(k) (K000554) are also included in the Cinescan S.
1
21683
Special 510(k) A.f2
Cinescan S
Ultrasonic Ophthalmic A and B scan System
510(k) Summary
Page :A 2 / 2
(4) Description
The Cinescan S is a combined ophthalmic A and B scan system that can also be used for biometric measurements of the eye and for IOL calculations.
(5) Intended Use
The Quantel Medical Cinescan S is intended to be used for :
- the Axial Length measurement of the eye by ultrasonic means
- the implanted IOL power calculation, using the Axial Length measurement.
- Visualization of the interior of the eye by A and B scans.
(6) Performance Data
(a) Non-Clinical tests
- for Electrical Security IEC 601-1 .
- IEC 601-1-2 for Electromagnetic Compatibility E
- FDA transducer emissions tests 赢
- (b) Clinical tests
Since the Cinescan uses the same technology as existing devices, clinical tests are not required.
(7) Conclusion
The Cinescan S is equivalent in safety and efficacy to the legally-marketed predicate devices.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features the department's name in a circular arrangement around a stylized symbol. The symbol consists of three overlapping human profiles facing to the right, representing health and human services. The text is in all caps and reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA".
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN 2 1 2002
Quantel Medical S.A. % George H. Myers, Sc.D. Official Agent Medsys, Inc. 377 Route 17 South HASBROUCK HEIGHTS NJ 07604
Re: K021683
Trade Name: Cinescan S Ophthalmic Ultrasound System Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulatory Class: II Product Code: 90 HPR and IYO Dated: May 20, 2002 Received: May 22, 2002
Dear Dr. Myers:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the Cinescan S. as described in your premarket notification:
Transducer Model Number
B-scan. 10MHz STD-A A-scan, 8MHz B-HF B-scan, 20 MHz
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Dr. Myers
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801, please contact the Office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at 301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html",
If you have any questions regarding the content of this letter, please contact Rodrigo C. Perez at (301) 594-1212.
Sincerely yours,
Nancy Brogdon
Nancy C. Brogdon Director, Division of Reproductive. Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure(s)
4
Quantel Medical
Diagnostic Ultrasound Indications for Use Form
Page 1 of of 4
510(k) Number (if known):
Device Name: Cinescan S
Intended Use: The intended use of the Cinescan S is for diagnostic imaging of the eye by A and B scans and for biometric measurements of the eye.
| CLINICAL
APPLICATION | A | B | M | PWD | CWD | COLOR
DOPPLER | POWER
(AMPLITUDE)
DOPPLER | COLOR
VELOCITY
IMAGING | COMBINED
(SPECIFY) | OTHER
(SPECIFY) |
|---------------------------------|---|---|---|-----|-----|------------------|---------------------------------|------------------------------|-----------------------|--------------------|
| Ophthamic | P | P | | | | | | | | |
| Fetal | | | | | | | | | | |
| Abdominal | | | | | | | | | | |
| Intra-operative
(specify) | | | | | | | | | | |
| Intra-operative
Neurological | | | | | | | | | | |
| Pediatric | | | | | | | | | | |
| Small Organ
(Specify) | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Cardiac | | | | | | | | | | |
| Trans-esophageal | | | | | | | | | | |
| Trans-rectal | | | | | | | | | | |
| Trans-vaginal | | | | | | | | | | |
| Trans-urethral | | | | | | | | | | |
| Intra-luminal | | | | | | | | | | |
| Peripheral
Vascular | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | |
| Musculo-Skeletal | | | | | | | | | | |
| Other (Snecify)* | | | | | | | | | | |
Mode of Operation
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
(PLEASE DO`NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 810.109) โ
Nancy C. Brandon
Division of Reprod and Radiological Dev 510(k) Number
5
Quantel Medical
Diagnostic Ultrasound Indications for Use Form
2 of of 4 Page
510(k) Number (if known):
Device Name: Cinescan S B-scan Transducer , 10 MHz
Intended Use: The intended use of the Cinescan S 10 MHz B-scan transducer is for diagnostic imaging of the eye by B scans..
| CLINICAL
APPLICATION | A | B | M | PWD | CWD | COLOR
DOPPLER | POWER
(AMPLITUDE)
DOPPLER | COLOR
VELOCITY
IMAGING | COMBINED
(SPECIFY) | OTHER
(SPECIFY) |
|------------------------------|---|---|---|-----|-----|------------------|---------------------------------|------------------------------|-----------------------|--------------------|
| Ophthamic | | E | | | | | | | | |
| Fetal | | | | | | | | | | |
| Abdominal | | | | | | | | | | |
| Intra-operative
(specify) | | | | | | | | | | |
| Intra-operative | | | | | | | | | | |
| Neurological | | | | | | | | | | |
| Pediatric | | | | | | | | | | |
| Small Organ | | | | | | | | | | |
| (Specify) | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Cardiac | | | | | | | | | | |
| Trans-esophageal | | | | | | | | | | |
| Trans-rectal | | | | | | | | | | |
| Trans-vaginal | | | | | | | | | | |
| Trans-urethral | | | | | | | | | | |
| Intra-luminal | | | | | | | | | | |
| Peripheral | | | | | | | | | | |
| Vascular | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | |
| Musculo-Skeletal | | | | | | | | | | |
| Other (Specify)* | | | | | | | | | | |
Mode of Operation
N= new indication; P= previously cleared by FDA; E= added under Appendix E Additional Comments
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use V (Per 21 CFR 810.109)
Nancy C. Brogdon
(Division Sign-Off) Division of Reproductive. Abdon and Radiological Devi 510(k) Number
6
Diagnostic Ultrasound Indications for Use Form
Page 3 3 of _ 4_
510(k) Number (if known):
Device Name: Quantel Medical S.A. "STD-A" A-scan 8 MHz transducer for "Cinescan S"
Intended Use: The Quantel Medical Cinescan * Mhz A-scan transducer is intended to be used with the Quantel Cinescan S A-scans of the eye and for biometric measurements.
| CLINICAL
APPLICATION | A | B | M | PWD | CWD | COLOR
DOPPLER | POWER
(AMPLITUDE)
DOPPLER | COLOR
VELOCITY
IMAGING | COMBINED
(SPECIFY) | OTHER
(SPECIFY) | |
|------------------------------|---|---|---|-----|-----|------------------|---------------------------------|------------------------------|-----------------------|--------------------|--|
| Ophthalmic | E | | | | | | | | | | |
| Fetal | | | | | | | | | | | |
| Abdominal | | | | | | | | | | | |
| Intra-operative
(specify) | | | | | | | | | | | |
| Intra-operative | | | | | | | | | | | |
| Neurological | | | | | | | | | | | |
| Pediatric | | | | | | | | | | | |
| Small Organ
(Specify) | | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | | |
| Cardiac | | | | | | | | | | | |
| Trans-esophageal | | | | | | | | | | | |
| Trans-rectal | | | | | | | | | | | |
| Trans-vaginal | | | | | | | | | | | |
| Trans-urethral | | | | | | | | | | | |
| Intra-luminal | | | | | | | | | | | |
| Peripheral
Vascular | | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | | |
| Musculo-Skeletal | | | | | | | | | | | |
| Other (Specify)* | | | | | | | | | | | |
Mode of Operation
N= new indication; P= previously cleared by FDA; E= added under Appendix E Additional Comments:
(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use | ✓ (Per 21 CFR 810.109) |
---|---|
------------------ | ------------------------------------------------------------------------------------------------------- |
(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
Nancy C Brogdon
510(k) Number | K021683 |
---|---|
--------------- | --------- |
7
Diagnostic Ultrasound Indications for Use Form
4 Page -
510(k) Number (if known):
Device Name: Cinescan S B-scan transducer B-HF 20 MHz
Intended Use: The intended use of the Cinescan S is for diagnostic imaging of the eye by B scans and for biometric measurements of the eye.
Mode of Operation
| CLINICAL | A | B | M | PWD | CWD | COLOR
DOPPLER | POWER
(AMPLITUDE)
DOPPLER | COLOR
VELOCITY
IMAGING | COMBINED
(SPECIFY) | OTHER
(SPECIFY) |
|---------------------------------|---|---|---|-----|-----|------------------|---------------------------------|------------------------------|-----------------------|--------------------|
| APPLICATION | | | | | | | | | | |
| Ophthamic | | E | | | | | | | | |
| Fetal | | | | | | | | | | |
| Abdominal | | | | | | | | | | |
| Intra-operative
(specify) | | | | | | | | | | |
| Intra-operative
Neurological | | | | | | | | | | |
| Pediatric | | | | | | | | | | |
| Small Organ
(Specify) | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | |
| Cardiac | | | | | | | | | | |
| Trans-esophageal | | | | | | | | | | |
| Trans-rectal | | | | | | | | | | |
| Trans-vaginal | | | | | | | | | | |
| Trans-urethral | | | | | | | | | | |
| Intra-luminal | | | | | | | | | | |
| Peripheral
Vascular | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | |
| Musculo-Skeletal | | | | | | | | | | |
| Other (Specify)* | | | | | | | | | | |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Additional Comments:
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Per 21 CFR 810.109) Prescription Use い
Nancy C Brogdon
(Division Sign-Division of Reproductive and Radiological Device 510(k) Number